中药调控自噬相关通路抗肺癌的研究进展

Research Progress of Chinese Medicine in Regulating Autophagy-Related Pathways Against Lung Cancer

  • 摘要: 肺癌作为全球高发病率和高死亡率的恶性肿瘤, 严重威胁着人类的生命健康。目前临床治疗肺癌主要以手术联合放疗、化疗等综合治疗为主, 可在一定程度上控制肺癌的进展, 但仍存在存活率低、生活质量差等问题。自噬是一种复杂的胞内自我降解机制, 自噬的启动与自噬相关基因蛋白及信号通路密切相关。研究表明, 合理地调控信号通路可以干预细胞自噬导致肺癌细胞死亡进而抑制肿瘤的生长。近年来, 中医药调控自噬相关信号通路抗肺癌已成为肿瘤研究领域的热点, 对近几年关于中医药调控自噬相关信号通路抗肺癌的研究进行梳理和总结, 以期为中医药防治肺癌的新药研发及临床应用提供参考依据。

     

    Abstract: As a malignant tumor with high incidence and mortality worldwide, lung cancer seriously threatens the life and health of human beings. At present, clinical treatment of lung cancer is mainly based on surgery combined with radiotherapy and chemotherapy and other comprehensive treatments, which can control the progression of lung cancer to a certain extent, but there are still problems such as low survival rate and poor quality of life. Autophagy is a complex intracellular self degradation mechanism. The occurrence of autophagy is closely related to autophagy-related gene proteins and signal pathways. Research shows that reasonable regulation of signal pathway can interfere with autophagy leading to lung cancer cell death and inhibit tumor growth. In recent years, the regulation of autophagy-related signaling pathways in Chinese medicine against lung cancer has become a hot spot in the field of oncology research. Therefore, this paper compares and summarizes the research on the regulation of autophagy-related signaling pathways in Chinese medicine against lung cancer in recent years, in order to provide a reference basis for the development of new drugs and clinical application of Chinese medicine against lung cancer.

     

/

返回文章
返回